Literature DB >> 8996658

Whole body lean mass is altered by dexamethasone treatment through reductions in protein and energy utilization in piglets.

H A Weiler1, Z Wang, S A Atkinson.   

Abstract

The objective of this study was to assess the effect of dexamethasone on growth, body composition and protein metabolism using the piglet as a model for rapidly growing premature infants. Seven-day-old male pigs (n = 18) were randomized to 0.5 mg/kg/day oral dexamethasone or placebo for 15 consecutive days. Weight and length gains and weight gained per energy or protein consumed were significantly lower in the dexamethasone group. Serum urea nitrogen was significantly higher in the dexamethasone group by day 15 of the study. No differences were observed between groups for urinary creatinine. The whole body percent lean mass was significantly lower and percent fat mass was significantly higher in the dexamethasone piglets, as measured by dual energy X-ray absorptiometry. In young piglets, dexamethasone, at doses similar to those in premature infants, induces protein catabolism, impairs growth and alters its composition.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8996658     DOI: 10.1159/000244397

Source DB:  PubMed          Journal:  Biol Neonate        ISSN: 0006-3126


  5 in total

1.  Regulation of corticoid and serotonin receptor brain system following early life exposure of glucocorticoids: long term implications for the neurobiology of mood.

Authors:  Delia M Vázquez; Charles R Neal; Paresh D Patel; Niko Kaciroti; Juan F López
Journal:  Psychoneuroendocrinology       Date:  2011-08-19       Impact factor: 4.905

2.  Oxidative stress in the developing brain: effects of postnatal glucocorticoid therapy and antioxidants in the rat.

Authors:  Emily J Camm; Deodata Tijsseling; Hans G Richter; Alexandra Adler; Jeremy A Hansell; Jan B Derks; Christine M Cross; Dino A Giussani
Journal:  PLoS One       Date:  2011-06-15       Impact factor: 3.240

3.  Antioxidant treatment improves neonatal survival and prevents impaired cardiac function at adulthood following neonatal glucocorticoid therapy.

Authors:  Youguo Niu; Emilio A Herrera; Rhys D Evans; Dino A Giussani
Journal:  J Physiol       Date:  2013-08-12       Impact factor: 5.182

4.  Antenatal glucocorticoid treatment affects hippocampal development in mice.

Authors:  Cornelle W Noorlander; Deodata Tijsseling; Ellen V S Hessel; Willem B de Vries; Jan B Derks; Gerard H A Visser; Pierre N E de Graan
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

5.  Response of the porcine MYH4-promoter and MYH4-expressing myotubes to known anabolic and catabolic agents in vitro.

Authors:  Madelaine C Brearley; David M Loczenski-Brown; Paul T Loughna; Tim Parr; John M Brameld
Journal:  Biochem Biophys Rep       Date:  2021-02-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.